Our research project aims to uncover the underlying mechanisms of autoimmune diseases (ADs) and type-2 inflammatory diseases (T2IDs). These chronic conditions cause inflammation and tissue damage, affecting millions of people worldwide. While treatments exist to alleviate symptoms, they can be expensive, often ineffective, and do not provide a cure. By understanding the genetic and epigenetic changes that drive these conditions, we hope to help in the development of more effective and personalized treatments.
ADs include widespread conditions such as rheumatoid arthritis and systemic lupus erythematosus, while T2IDs encompass diseases like asthma and chronic rhinosinusitis with nasal polyps. These diseases present significant challenges for patients and healthcare systems due to their chronic nature and the need for long-term treatment.
Our goal is to better understand the underlying causes of these diseases by examining genetic and environmental factors and their influence on the immune system’s response. We intend to apply cutting-edge and robust methods such as GWAS, fine-mapping, and QTL analysis.
This project is planned to run for three years, allowing us enough time to conduct in-depth genetic and epigenetic analyses, validate our findings, and explore potential therapeutic targets, as well as generate data that can be used by the scientific community.
We expect that our research will have a significant public health impact. Proper stratification of patients based on their genetic heterogeneity can lead to improvements in their clinical situation through more accurate diagnoses, better prediction of treatment response, and personalized therapies. Ultimately, our findings could reduce the burden of these diseases by enhancing the effectiveness of treatments and improving the quality of life for millions of patients worldwide.
In conclusion, our research project seeks to unravel the heterogeneity complexities of ADs and T2IDs, providing new insights into their underlying mechanisms using established and robust methodologies. This research has the potential to significantly improve the lives of millions of people.
